.

Pharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

TORISEL Drug Profile

« Back to Dashboard

Which patents cover Torisel, and what substitute generic drugs are available?

Torisel is a drug marketed by Pf Prism Cv and is included in one NDA. There are seven patents protecting this drug and one Paragraph IV challenge.

This drug has forty-three patent family members in twenty-eight countries.

The generic ingredient in TORISEL is temsirolimus. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the temsirolimus profile page.

Summary for Tradename: TORISEL

Patents:7
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list26
Clinical Trials: see list118
Patent Applications: see list818
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TORISEL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pf Prism Cv
TORISEL
temsirolimus
SOLUTION;INTRAVENOUS022088-001May 30, 2007RXYesYes5,362,718*PED► SubscribeY► Subscribe
Pf Prism Cv
TORISEL
temsirolimus
SOLUTION;INTRAVENOUS022088-001May 30, 2007RXYesYesRE44768*PED► Subscribe ► Subscribe
Pf Prism Cv
TORISEL
temsirolimus
SOLUTION;INTRAVENOUS022088-001May 30, 2007RXYesYes8,455,539*PED► SubscribeY► Subscribe
Pf Prism Cv
TORISEL
temsirolimus
SOLUTION;INTRAVENOUS022088-001May 30, 2007RXYesYes8,026,276*PED► SubscribeY► Subscribe
Pf Prism Cv
TORISEL
temsirolimus
SOLUTION;INTRAVENOUS022088-001May 30, 2007RXYesYes8,299,116*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: TORISEL

Drugname Dosage Strength RLD Submissiondate
temsirolimusInjection25 mg/mL, 1.8 mL vialTorisel5/25/2011

International Patent Family for Tradename: TORISEL

Country Document Number Estimated Expiration
Austria234307► Subscribe
Australia679854► Subscribe
Slovenia1266899► Subscribe
Austria537176► Subscribe
European Patent Office1760083► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: TORISEL

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C017/2008Ireland► SubscribeSPC017/2008: 20090911, EXPIRES: 20200413
2008009Lithuania► SubscribePRODUCT NAME: TEMSIROLIMUSUM; REG. NO/DATE: EU/1/07/424/001 20071119
438Luxembourg► Subscribe91438, EXPIRES: 20200414
2008009,C0763039Lithuania► SubscribePRODUCT NAME: TEMSIROLIMUSUM; REGISTRATION NO/DATE: EU/1/07/424/001 20071119
C/GB08/025United Kingdom► SubscribePRODUCT NAME: TEMSIROLIMUS AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/07/424/001 20071119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc